872356-79-1

Upstream product

• 872356-92-8 (2S,3S,4R)-3,4-bis(tert-butyldimethylsilanyloxy)-2-tetracosanoylamino-1-nonanol 
• 143615-35-4 2,3,4,6-tetra-O-benzyl-D-galactopyranosyl fluoride 
• 872356-91-7 (2S,3S,4R)-1,3,4-tris(tert-butyldimethylsilanyloxy)-2-tetracosanoylaminononane 
• 101966-50-1 2,3,4,6-tetrakis-O-(phenylmethyl)-β-D-galactopyranosyl fluoride 
• 872356-78-0 (2S,3S,4R)-2-tetracosanoylamino-1,3,4-nonanetriol 
• 872356-77-9 (2S,3S,4R)-2-amino-1,3,4-nonanetriol 

Downstream Products

• 383187-82-4 OCH 
• 745042-02-8 (2S,3S,4R)-1-(2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyloxy)-2-(tetracosanoylamino)nonane-3,4-diol 

Relevant academic research and scientific papers

RCAI-17, 22, 24-26, 29, 31, 34-36, 38-40, and 88, the analogs of KRN7000 with a sulfonamide linkage: Their synthesis and bioactivity for mouse natural killer T cells to produce Th2-biased cytokines

RCAI-17, 22, 24-26, 29, 31, 34-36, 38-40, and 88, the analogs of KRN7000 (1) with a sulfonamide linkage instead of an amide bond, were synthesized to examine their bioactivity for mouse natural killer (NK) T cells. RCAI-17, 22, 24-26, 29, 31, 34-36, and 8

Synthesis and evaluation of sphinganine analogues of KRN7000 and OCH

The phytosphingosine-containing α-galactosylceramides (α-GalCers), KRN7000 and OCH, have been shown to activate NKT cells via interaction with CD1d, a member of the CD1 family of antigen presenting proteins. Evidence from KRN7000 stimulation of NKT cells